Aduro Clean Technologies (ACT) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
1 Jul, 2025Executive summary
Achieved transformative milestones, including uplisting to Nasdaq and a successful US public offering raising US$4.52 million.
Engaged Zeton to develop a Hydrochemolytic pilot facility, advancing commercialization efforts.
Signed MOU with GF Building Flow Solutions Americas to address recycling of crosslinked polyethylene waste.
Showcased technology at major industry conferences and expanded outreach through podcasts and international events.
Financial highlights
Q2 2025 revenue was $38,143, down 48% year-over-year; six-month revenue was $93,143, down 29%.
Loss from operations increased to $3.11 million in Q2 2025 from $2.08 million in Q2 2024, driven by growth and uplisting costs.
Cash position stood at $9.2 million as of November 30, 2024.
Property, plant, and equipment carrying cost rose to $4.1 million, reflecting investment in research and lab facilities.
Outlook and guidance
Proceeds from the public offering will fund R&D, pilot plant construction, and general corporate purposes.
Pilot plant with Zeton on track for delivery and commissioning by Q3 2025.
Management anticipates achieving full market readiness and sustainable growth through commercialization.
Latest events from Aduro Clean Technologies
- Innovative recycling tech enables low-cost, scalable plastic waste conversion, with strong industry traction.ACT
LD Micro Main Event XIX Investor Conference3 Feb 2026 - Q2 2026 delivered strong revenue growth and capital raise, advancing scale-up and demonstration plans.ACT
Q2 202615 Jan 2026 - Innovative recycling platform targets landfill plastics with scalable, flexible business models.ACT
H.C. Wainwright 27th Annual Global Investment Conference31 Dec 2025 - Pilot plant commissioning advanced, cash reserves grew, but revenue fell and losses widened.ACT
Q1 202630 Dec 2025 - Pilot plant progress, industry collaborations, and strong financing offset lower revenue and higher losses.ACT
Q4 202522 Sep 2025 - Revenue surged 208% year-over-year as technology and global partnerships advanced.ACT
Q4 20241 Jul 2025 - Advanced R&D, new patent, and strong cash position support technology scale-up and growth.ACT
Q1 20251 Jul 2025 - Q3 2025 saw lower revenue and higher losses, but key milestones and strong cash support growth.ACT
Q3 20251 Jul 2025